Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (24,416)	$ (19,434)	$ (11,202)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense	5,848	5,072	3,350
Stock-based compensation expense	28,986	30,020	24,179
Change in fair value of contingent consideration	(4,135)	196	1,778
Deferred taxes		(2,510)
Provision for (recovery of) bad debt	693	(41)	105
Unrealized foreign currency transaction (gains) losses	(9)	24
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	5,362	10,511	(13,970)
Prepaid expenses and other current assets	(2,111)	1,801	4,465
Commissions receivable, current and non-current	(24,240)	(16,871)	(5,829)
Operating lease right-of-use assets	2,613	2,710	2,076
Other assets	(19)	534	1,433
Accounts payable	1,124	(3,968)	9,301
Accrued expenses and other current liabilities	(2,375)	2,692	(3,968)
Deferred revenue	(229)	227	368
Operating lease liabilities	(2,883)	(2,840)	(2,233)
Other long-term liabilities		(934)	815
Net cash provided by (used in) operating activities	(15,791)	7,189	10,668
Cash flows from investing activities:
Acquisition of property and equipment, including costs capitalized for development of internal-use software	(4,290)	(2,862)	(3,822)
Acquisition of business		(15,955)	(14,930)
Net cash used in investing activities	(4,290)	(18,817)	(18,752)
Cash flows from financing activities:
Proceeds from exercise of stock options	942	3,615	4,907
Proceeds from private placement of common stock	15,000
Tax withholding payments related to net share settlement	(100)
Net cash provided by financing activities	15,842	3,615	4,907
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(27)	(6)	(7)
Net decrease in cash, cash equivalents and restricted cash	(4,266)	(8,019)	(3,184)
Cash, cash equivalents and restricted cash at beginning of period	35,101	43,120	46,304
Cash, cash equivalents and restricted cash at end of period	30,835	35,101	43,120
Supplemental disclosure of noncash investing and financing information:
Acquisition of property and equipment included in accounts payable	60	100
Fair value of contingent consideration in connection with acquisition included in stockholders' equity			1,335
Fair value of contingent consideration in connection with acquisition included in liabilities		3,784	416
Operating lease liabilities arising from obtaining right-of-use assets	1,096	383	541
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	30,835	34,851	42,870
Restricted cash (included in other assets)		250	250
Cash, cash equivalents and restricted cash at end of period	30,835	$ 35,101	$ 43,120
Settle Contingent Consideration Liability
Supplemental disclosure of noncash investing and financing information:
Issuance of Class A common stock	1,889
Settle Stock-Based Compensation Liability
Supplemental disclosure of noncash investing and financing information:
Issuance of Class A common stock	$ 164